loading...

Addiction Severity Index – Lite: Clinical Trials Network Version – Part 1 (ASI - Lite: Clinical Trials Network Version – Part 1 )

McLellan AT; Luborsky L; Woody GE; O'Brien CP

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

  • Published in 1980
Authors

McLellan AT; Luborsky L; Woody GE; O'Brien CP

Copyright
Public Domain
Objective
To produce a problem severity profile of each patient through an analysis of six general areas
Therapeutic area
  • Mental Disorders
  • Chemically-Induced Disorders
Therapeutic indication
  • Substance-Related Disorders
  • Alcoholism
Type of Clinical Outcome Assessment (COA)
  • Composite
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire
McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980 Jan;168(1):26-33 (PubMed Abstract)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

McLellan AT; Luborsky L; Woody GE; O'Brien CP

Thomas McLellan

Treatment Research Institute
600 Public Ledger Building
150 S. Independence Mall West
Philadelphia
PA 19106
USA

Thomas McLellan Publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

This questionnaire is in the public domain.

Distribution of Translations

Existing translations produced by Mapi can be obtained from Mapi Research Trust

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner

Fees may apply to your project.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

No translation

Conditions to translate

In case further linguistic validation steps need to be performed on the translations produced by Mapi and provided by Mapi Research Trust, User shall work exclusively with Mapi. Each such upgraded version will be made available to third parties exclusively by Mapi Research Trust under the same conditions as described above.

More information on translations

Copies of the Danish, Lithuanian, Polish, Portuguese and Swedish versions: available on the Evaluation Instruments Bank (EIB) of the European Monitoring Centre for Drugs and Drug Addiction website.